Literature DB >> 7370167

Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro.

H Eichholtz, K R Trott.   

Abstract

Chinese hamster, HeLa and HAK cells were treated with methotrexate (MTX) to determine the dependence of its effect on drug concentration and exposure time. With a broad range of survival curves for Chinese hamster cells, cell survival is an exponential function of exposure time and a power function of drug concentration. The data allow a mathematical description to be made of the interdependence of MTX concentration and drug exposure in relation to cell survival.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370167      PMCID: PMC2010205          DOI: 10.1038/bjc.1980.40

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.

Authors:  N Jaffe
Journal:  Cancer Chemother Rep       Date:  1974 Mar-Apr

2.  Active transport of aminopterin in Yoshida sarcoma cells.

Authors:  A Y Divekar; N R Vaidya; B M Braganca
Journal:  Biochim Biophys Acta       Date:  1967

3.  Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.

Authors:  I Djerassi; C J Rominger; J S Kim; J Turchi; U Suvansri; D Hughes
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

4.  Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.

Authors:  I D Goldman; N S Lichtenstein; V T Oliverio
Journal:  J Biol Chem       Date:  1968-10-10       Impact factor: 5.157

5.  On the nature of permeability of sarcoma-180 cells to amethopterin in vitro.

Authors:  M T Hakala
Journal:  Biochim Biophys Acta       Date:  1965-05-25

6.  Some observations on the combined effects of x-rays and methotrexate on human tumor cells in vitro with possible relevance to their most useful combination in radiotherapy.

Authors:  R J Berry
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-03

7.  Cell killing studies on the mode of action of methotrexate on L-cells in vitro.

Authors:  J Borsa; G F Whitmore
Journal:  Cancer Res       Date:  1969-04       Impact factor: 12.701

8.  Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.

Authors:  W R Bruce; B E Meeker; W E Powers; F A Valeriote
Journal:  J Natl Cancer Inst       Date:  1969-06       Impact factor: 13.506

9.  An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer.

Authors:  R H Creech; R B Catalano; M J Mastrangelo; P F Engstrom
Journal:  Cancer       Date:  1975-04       Impact factor: 6.860

10.  Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle.

Authors:  W K Sinclair
Journal:  Science       Date:  1965-12-24       Impact factor: 47.728

View more
  6 in total

1.  A slow-release methotrexate formulation for intrathecal chemotherapy.

Authors:  E Chatelut; T Kim; S Kim
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma.

Authors:  N L Gilchrist; J Caldwell; I D Watson; D Cunningham; G J Forrest; M Soukop; M Stewart; W Fitch
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.

Authors:  S B Howell; B B Chu; W E Wung; B M Metha; J Mendelsohn
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

4.  An extended-release formulation of methotrexate for subcutaneous administration.

Authors:  A Bonetti; E Chatelut; S Kim
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Quantitation of chemosensitivity in acute myelocytic leukaemia.

Authors:  M G Lihou; P J Smith
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

6.  Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro.

Authors:  H Eichholtz-Wirth
Journal:  Br J Cancer       Date:  1980-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.